Theta Burst Stimulation Plus Habit Override Training for Compulsive Behaviors
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04580043 |
Recruitment Status :
Recruiting
First Posted : October 8, 2020
Last Update Posted : August 16, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Compulsive Behavior Obsessive-Compulsive Disorder | Behavioral: Habit Override Practice Device: Transcranial Magnetic Stimulation Behavioral: Sham Training Device: Sham Transcranial Magnetic Stimulation | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 200 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Primary Purpose: | Basic Science |
Official Title: | Experimental Manipulation of OFC Function and Behavioral Context: Towards an Integrative Translational Model of Compulsive Behaviors |
Actual Study Start Date : | December 28, 2020 |
Estimated Primary Completion Date : | January 2, 2026 |
Estimated Study Completion Date : | January 2, 2027 |

Arm | Intervention/treatment |
---|---|
Experimental: cTBS + Habit Override Training
Transcranial Magnetic Stimulation delivered in a continuous Theta Burst Stimulation (cTBS) pattern, paired with Habit Override Training.
|
Behavioral: Habit Override Practice
Computerized "brain training" to provide practice in overriding avoidance habits. Device: Transcranial Magnetic Stimulation Non-invasive method for temporary, focal stimulation of brain areas. Delivered in a continuous Theta Burst Stimulation (TBS) pattern.
Other Name: cTBS |
Active Comparator: Sham TBS + Habit Override Training
Sham Transcranial Magnetic Stimulation, paired with Habit Override Training.
|
Behavioral: Habit Override Practice
Computerized "brain training" to provide practice in overriding avoidance habits. Device: Sham Transcranial Magnetic Stimulation Sham stimulation of non-brain areas. Delivered in a continuous Theta Burst Stimulation (TBS) pattern.
Other Name: Sham cTBS |
Active Comparator: cTBS + Sham Training
Transcranial Magnetic Stimulation delivered in a continuous Theta Burst Stimulation (cTBS) pattern, paired with Sham Training.
|
Device: Transcranial Magnetic Stimulation
Non-invasive method for temporary, focal stimulation of brain areas. Delivered in a continuous Theta Burst Stimulation (TBS) pattern.
Other Name: cTBS Behavioral: Sham Training Computer-based task practice in a non-active/inert task. |
Sham Comparator: Sham TBS + Sham Training
Sham Transcranial Magnetic Stimulation, paired with Sham Training.
|
Behavioral: Sham Training
Computer-based task practice in a non-active/inert task. Device: Sham Transcranial Magnetic Stimulation Sham stimulation of non-brain areas. Delivered in a continuous Theta Burst Stimulation (TBS) pattern.
Other Name: Sham cTBS |
- Brain activation in target region [ Time Frame: 10-60min post-intervention ]Mean Cerebral Blood Flow (CBF) in orbitofrontal cortex collected via functional Magnetic Resonance Imaging (fMRI)
- Effort to resist compulsive behaviors in response to laboratory triggers [ Time Frame: 60min post-intervention ]Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: self-reported effort needed to resist (0-100 scale)
- Duration of compulsive behaviors in response to laboratory triggers [ Time Frame: 60min post-intervention ]Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: duration of compulsive behavior performance (% of total time allotted)
- Intensity of urges to perform compulsive behaviors in response to laboratory triggers [ Time Frame: 60min post-intervention ]Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: self-reported urge intensity (0-100 scale)
- Goal-directed cognition [ Time Frame: 90min-1 week ]Neuropsychological test of flexible goal-directed cognition (two-step task): switch score (higher score=better performance)
- Yale-Brown Obsessive Compulsive Scale (Y-BOCS) [ Time Frame: 1 week ]Clinician-administered measurement of obsessions and compulsions (range: 0-40; higher score=worse outcome)
- WHO Disability Assessment Scale 2.0 [ Time Frame: 1 week ]Self-report measure of general functioning and disability (0-100; higher score=worse outcome)
- Obsessive Compulsive Inventory-Revised (OCI-R) [ Time Frame: 1 week ]Self-report measure of obsessions and compulsions (0-72; higher score=worse outcome)
- Effort to resist compulsive behaviors in response to laboratory triggers [ Time Frame: 1 week ]Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: self-reported effort needed to resist (0-100 scale)
- Duration of compulsive behaviors in response to laboratory triggers [ Time Frame: 1 week ]Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: duration of compulsive behavior performance (% of total time allotted)
- Intensity of urges to perform compulsive behaviors in response to laboratory triggers [ Time Frame: 1 week ]Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: self-reported urge intensity (0-100 scale)
- Brain activation in target region [ Time Frame: 1 week ]Mean Cerebral Blood Flow (CBF) in orbitofrontal cortex collected via functional Magnetic Resonance Imaging (fMRI)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Participants will:
- Be between the ages of 18 and 60 years
- Endorse problematic compulsive behaviors, per self-report and clinician-administered measures.
- Agree to video taping of structured clinical interview
- Report that they will reside in the Pittsburgh area for at least 5 weeks
Exclusion Criteria:
- Failure to meet standard MRI inclusion criteria: those who endorse claustrophobia, those who have cardiac pacemakers, neural pacemakers, surgical clips in the brain or blood vessels, surgically implanted metal plates, screws or pins, cochlear implants, implanted uterine devices, metal braces, or other metal objects in their body, especially in the eye. Dental fillings do not present a problem. Plastic or removable dental appliances do not require exclusion. History of significant injury or surgery to the brain or spinal cord that would impair interpretation of results. Pregnancy, determined by pregnancy tests on females.
-
Medical contraindications for Transcranial Magnetic Stimulation (TMS):
- Presence of a neurologic disorder or medication therapy known to alter seizure threshold (e.g., stroke, aneurysm, brain surgery, structural brain lesion, brain injury, frequent/severe headaches)
- Recurrent seizures or epilepsy in participant or family history of hereditary epilepsy
- Pregnancy
- Metallic implants in body or other devices that may be affected by magnetic field
- Significant heart disease or cerebrovascular disease
- Medications with seizure threshold lowering potential, e.g., clomipramine, Monoamine Oxidase inhibitors (MAOi's), imipramine, clozapine
- Acute suicidality or other psychiatric crises requiring treatment escalation
- Changes made to treatment regimen within 4 weeks of baseline assessment
- Reading level <6th grade
- Presence of bipolar, psychotic, autism spectrum, or substance use disorder (i.e. current use of mood altering drugs such as cocaine, cannabis or marijuana, opiates, amphetamines, and barbiturates)
- Presence of movement disorder or tics affecting manual responses
- Inability to read text from 2 feet away (corrective lenses allowed)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04580043
Contact: Rebecca Price, PhD | 4126486445 | canlab@pitt.edu |
United States, Pennsylvania | |
Western Psychiatric Institute and Clinic | Recruiting |
Pittsburgh, Pennsylvania, United States, 15213 | |
Contact: Rebecca Price, PhD 412-648-6445 canlab@pitt.edu |
Principal Investigator: | Rebecca B Price, PhD | University of Pittsburgh |
Responsible Party: | Rebecca Price, Associate Professor of Psychiatry, University of Pittsburgh |
ClinicalTrials.gov Identifier: | NCT04580043 |
Other Study ID Numbers: |
STUDY19090219 (Part 2) R01MH124707 ( U.S. NIH Grant/Contract ) |
First Posted: | October 8, 2020 Key Record Dates |
Last Update Posted: | August 16, 2022 |
Last Verified: | August 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Obsessive-Compulsive Disorder Compulsive Behavior Mental Disorders Anxiety Disorders Impulsive Behavior |